← Clinical Trials
Brief Video-based Intervention NA Continuous Endpoint NCT04497415

The COVID-19 and Healthcare Workers: An Active Intervention: Complete Statistical Analysis

This analysis concerns a randomized study of a brief video intervention for healthcare workers during COVID-19. The registry record describes help-seeking behavior as the primary outcome, but does not report the outcome estimates needed to assess the intervention’s observed effect.

Trial start: 2020-10-21  ·  Enrollment: 350  ·  Sponsor: Research Foundation for Mental Hygiene, Inc.
Scope of this record

This page provides an independent statistical analysis and educational interpretation of publicly reported results. ClinicalTrials.gov provides the official trial registry record. Numerical trial results on this page are restricted to the results posted in the ClinicalTrials.gov record; calculations added by Clinical Biostats are labelled as such.

1. Trial at a Glance

This page covers the registry results for The COVID-19 and Healthcare Workers: An Active Intervention (NCT04497415), a randomized na study. The primary outcome is Help-seeking Behavior.

350
Enrollment
NA
n/a
Arms
In the primary outcome
n/a
Effect
No re-analysis shown
n/a
95% CI
See limitations
FeatureRegistry value
ClinicalTrials.gov identifierNCT04497415
PhaseNA
ConditionBrief Video-based Intervention, Non Intervention Control
AllocationRandomized
Design modelParallel
MaskingSingle
Enrollment350
Arms in the primary outcomen/a
Lead sponsorResearch Foundation for Mental Hygiene, Inc.
Results postedYes

2. Clinical Question

Population

Healthcare providers were the population of interest. The study summary describes recruitment through Amazon Turk and refers to pre-, post- and follow-up assessments. It also describes the population as including providers in areas characterized as having higher or lower COVID-19 risk. The registry record lists enrollment of 350, while the brief summary refers to N=1,200; it does not explain the difference between these figures.

Intervention

The registered intervention is a brief video about coping with COVID-19 stress. The summary describes a personal story about a healthcare provider’s experiences, struggles and barriers to care. It also outlines a video on day 1, with different day 14 arrangements in the intervention descriptions. The registry record does not make clear which version corresponds to the registered intervention arm.

Comparator

The registered comparator is assessment only, described as a control. The summary characterizes the no-intervention control as questionnaires only. It also describes an additional arrangement involving a day 1 video and a written story on day 14, but the arm descriptions do not list that as a separate registered group.

Primary question

The primary outcome is help-seeking behavior, measured with the Attitudes Towards Seeking Professional Psychological Help Scale. The clinical question is whether the video-based intervention is associated with a change in treatment-seeking intentions compared with assessment only across the stated assessments. The registry record does not report the outcome estimates or a primary comparison, so it cannot establish the direction or size of any observed difference.

3. Trial Design

The registry record classifies this as a randomized, single-masked, parallel study. It lists enrollment of 350 and a completed status. The recorded start date is 2020-10-21 and the primary completion date is 2020-11-30. The phase is listed as NA. The registry record does not report who was masked, how randomization was generated, or whether allocation was concealed.

The registered intervention is a video-based intervention, and the registered comparison is assessment only. The brief summary, however, describes three arrangements: a video on day 1 and a booster video on day 14; a day 1 video and written story on day 14; and a no-intervention control. In contrast, the registered arm descriptions name only the video-based intervention and assessment only. The registry record does not reconcile these descriptions, so the exact group structure cannot be determined from the record alone.

The summary says assessments were planned before and after intervention, with follow-up on day 14 and day 30. The primary outcome timeframe gives baseline and post-intervention assessments on day 1, followed by the same two follow-up times. This describes repeated measurement, rather than a single endpoint measurement. The summary also names aims concerning stigma, fear, help-seeking, geographic risk and symptoms of depression, anxiety, PTSD and moral injury. The registry record lists five outcome measures and zero analysis entries, but does not provide a full statistical analysis plan or results for the primary outcome.

The enrollment entry and the population figure in the brief summary differ: the record lists 350, whereas the summary refers to N=1,200. The record does not explain whether these numbers refer to different recruitment goals, study versions or analytic populations. The sample-size rationale and any amendments to enrollment are not reported in the registry record.

4. Participant Flow and Accounting

The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.

Overall Study

StageVideo-based InterventionAssessment Only
STARTED229121
Post-intervention Assessment (Day 1)229121
First Follow-up Assessment (Day 14)195102
COMPLETED18694
NOT COMPLETED4327

Reasons for not completing this period:

ReasonVideo-based InterventionAssessment Only
Lost to Follow-up4327

Analysis population for the primary outcome, as defined in the registry: Fifty-three participants were lost to follow-up before first follow-up (day 14) and 70 were lost to follow-up before second follow-up (day 30).

5. Baseline Characteristics

The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.

CharacteristicUnitVideo-based InterventionAssessment OnlyTotal
Participants analysed229121350
Age, Continuousyears35.3 (SD 11.5)33.8 (SD 11.5)34.8 (SD 11.5)
Sex: Female, Male: FemaleParticipants16595260
Sex: Female, Male: MaleParticipants642690
Ethnicity (NIH/OMB): Hispanic or LatinoParticipants28634
Ethnicity (NIH/OMB): Not Hispanic or LatinoParticipants201115316
Ethnicity (NIH/OMB): Unknown or Not ReportedParticipants000
Race (NIH/OMB): American Indian or Alaska NativeParticipants325
Race (NIH/OMB): AsianParticipants231538
Race (NIH/OMB): Native Hawaiian or Other Pacific IslanderParticipants000
Race (NIH/OMB): Black or African AmericanParticipants311546
Race (NIH/OMB): WhiteParticipants17086256
Race (NIH/OMB): More than one raceParticipants000
Race (NIH/OMB): Unknown or Not ReportedParticipants235
Region of Enrollment: United Statesparticipants229121350
Occupation: NurseParticipants15681237
Occupation: PhysicianParticipants371552
Occupation: EMTParticipants201030
Occupation: OtherParticipants161531
Exposure to COVID-19Participants10546151

6. Primary Endpoint

The registry lists the primary outcome as Help-seeking Behavior, measured over Assessed at baseline and post-intervention (both day 1), first follow-up (day 14), and second follow-up (day 30).

ElementRegistry entry
Result typeMean
Measure of spread95% Confidence Interval
Unitunits on a scale
Endpoint classificationContinuous Endpoint

The primary endpoint is help-seeking behavior, measured as the mean on the Attitudes Towards Seeking Professional Psychological Help Scale (ATSPPH). The record states that total scores range from 3 to 12 and that higher scores indicate greater treatment-seeking intentions. The stated unit is units on a scale, and the planned summary statistic is a mean with a 95% confidence interval.

This measure addresses stated attitudes or intentions toward seeking professional psychological help. It is not itself a record of whether participants actually sought care. That distinction matters when interpreting an outcome described as help-seeking behavior: the registry’s measure is specifically a scale of attitudes and intentions, so conclusions should stay within that construct.

The record lists assessments at baseline and post-intervention, both on day 1, then at day 14 and day 30. Repeated assessments can describe how scores vary over time, but interpreting an intervention effect requires a clearly specified comparison between groups and a defined time point or longitudinal analysis. The record does not report which time point constitutes the primary comparison, nor does it provide a numerical mean, confidence interval, or effect estimate. It therefore does not show how the scale scores changed or how precisely any group difference was estimated.

A confidence interval, in general, expresses statistical uncertainty around an estimate under the method used to construct it. Its width reflects precision, but it does not by itself establish clinical importance or eliminate possible bias. No numerical interval for this endpoint is reported in the registry record.

7. Why No Re-analysis Is Shown

Reported as posted, not recalculated. Primary outcome has several categories or time points; not reduced to one comparison. A result is recalculated only when the posted data support a clean two-arm comparison, so no result is shown beyond what the sponsor posted.

8. Statistical Interpretation

Clinical Biostats interpretation

The available record identifies the primary outcome and its measurement schedule, but does not report a numerical result for it. There is no posted mean, between-group contrast, confidence interval, or test statistic for help-seeking behavior. The registry record also lists zero analysis entries. As a result, the observed direction, magnitude and precision of the primary outcome cannot be assessed from these data.

The record notes that the primary outcome has several categories or time points and is not reduced to one comparison. That is important because the measurements span baseline, post-intervention, day 14 and day 30. A result at one assessment may differ from a result at another, and repeated observations on the same participant are related. Without the analysis definition, it is not possible to know which contrast would be the primary basis for an efficacy conclusion, or how repeated observations were handled.

The study summary describes aims that extend beyond help-seeking, including stigma, fear, comparisons by area-level risk and changes in mental health symptoms. Those aims do not substitute for a reported primary endpoint result. The record lists five outcome measures but does not provide results or an analysis plan that would clarify how each measure relates to the primary question. No conclusions about those other outcomes can be drawn from the registry information presented.

The follow-up description reports losses before the day 14 and day 30 assessments. Such missing observations can affect estimates if the participants with missing outcomes differ systematically from those observed. The record does not report reasons for loss, group-specific missingness, methods for handling missing values, or sensitivity analyses. Therefore the extent to which missing follow-up data could influence the outcome estimates is not assessable.

The appropriate reading is limited: the registry records a randomized study with a stated scale-based primary outcome, but the registry record does not report the result needed to estimate an intervention effect. It would be inaccurate to infer benefit, lack of benefit, or equivalence from the absence of a posted estimate. The absence of a result is a reporting limitation, not evidence that the groups had the same outcomes.

9. Statistical Methods Explained

What does a mean describe?

For a continuous outcome such as a scale score, the mean describes the average score in a group at a specified assessment. The primary outcome is defined as the mean ATSPPH score, with higher scores indicating greater treatment-seeking intentions. A mean is useful for describing the overall level of scores, but it does not show how scores are distributed among individuals. It also does not by itself estimate an intervention effect. For that, a defined comparison is needed, such as a difference between group means at a specified time or a contrast in change over time.

The registry record identifies the measurement times but does not report a chosen primary contrast or numerical estimates. With repeated measurements, analysts must account for the fact that observations from the same participant are related. Treating every assessment as independent would generally fail to represent that within-person relationship. The statistical model and its assumptions are not reported in the registry record.

What does a 95% confidence interval communicate?

In general, a confidence interval gives a range of values compatible with the observed data under the statistical model and interval-construction method. A narrower interval indicates greater precision than a wider interval, all else being equal. A confidence interval is not a guarantee that the true value lies in that particular interval, and it does not address all sources of bias, measurement error or uncertainty about the model.

The registry record says that the primary outcome is to be reported as a mean with a 95% confidence interval. It does not give the interval limits or the mean. Consequently, neither the estimated score nor its precision can be interpreted from the registered results. The interval for a group mean would also be different in meaning from an interval for a between-group contrast; the record does not specify or report the latter.

Why does the comparison need a defined time point?

The endpoint schedule includes baseline and post-intervention measurements on day 1, plus follow-ups on day 14 and day 30. An intervention effect could be defined as a between-group difference at follow-up, a difference in change from baseline, or a model-based contrast over multiple assessments. These approaches answer related but not identical questions. A prespecified analysis helps distinguish the primary comparison from secondary or exploratory ones. The statistical plan and the selected primary contrast are not reported in the registry record.

General statistical practice also distinguishes within-group change from a randomized between-group comparison. A change in one group alone cannot establish that the intervention caused the change, because changes may also occur in the comparison group. A randomized comparison is intended to evaluate differences between assigned groups, subject to appropriate analysis and the limitations of missing data, measurement and implementation. No numerical comparison is reported for this endpoint.

What is the role of randomization?

Random assignment is intended, in general, to make groups comparable at the start of a study with respect to both measured and unmeasured characteristics, on average. It does not guarantee exact balance in a particular study, and it does not resolve problems that arise after assignment, such as differential loss to follow-up or deviations from the assigned intervention. The record classifies allocation as randomized but does not describe sequence generation, allocation concealment, or the analysis population.

The record also labels masking as single. The identity of the masked party is not reported in the registry record. Masking can reduce some forms of bias in outcome assessment or participant behavior, depending on who is masked and how the outcome is measured. A self-reported scale may be affected by expectations or awareness of group assignment; the available record does not describe safeguards against such effects.

How should planning illustrations be read?

General sample-size planning asks how many participants per arm would be needed to detect an effect under stated assumptions, such as a significance level, allocation pattern, outcome variability and target effect. The record describes planning illustrations based on the observed effect, a two-sided significance level of 0.05, equal allocation, and a normal approximation. It also states that the effect to detect is a stated fraction of the observed effect.

These are planning illustrations, not observed power and not proof that the study was adequately or inadequately powered. Their interpretation depends on the effect estimate used and the assumptions applied. The registry record does not report a sample-size justification for the trial’s own design. The primary outcome is not reported as one comparison, and no observed endpoint estimate is available in the record, so the planning assumptions should not be mistaken for evidence about the intervention’s effect.

General principles for continuous outcomes also include attention to variability and model fit. If the outcome distribution is highly skewed, bounded, or otherwise inconsistent with model assumptions, the mean and its uncertainty may need careful interpretation. The ATSPPH score has a stated range, but the record does not report its observed distribution, variability, or the model used. No assessment of those assumptions can therefore be made from the registry record.

10. Multiplicity, Missing Data and Analysis Populations

The record identifies several assessment times for the primary outcome and describes multiple study aims. Testing multiple outcomes, time points, subgroups or contrasts can increase the chance of at least one apparently notable result arising by chance. In general, a prespecified hierarchy or multiplicity adjustment can help control that risk; alternatively, analyses may be labeled exploratory. The statistical plan, multiplicity strategy and distinction between confirmatory and exploratory analyses are not reported in the registry record.

The primary outcome is explicitly not reduced to one comparison because it has several categories or time points. Without a defined primary contrast, readers cannot determine which estimate would carry the primary inferential interpretation. The record lists five outcome measures and zero analysis entries, but that does not identify how many comparisons were planned or performed.

For missing data, the primary outcome description states that 53 participants were lost to follow-up before the first follow-up on day 14 and 70 were lost before the second follow-up on day 30. These are reported as losses before follow-up; the record does not state the reasons, timing beyond those descriptions, or distribution by group. It also does not state how missing outcomes were handled, whether participants were analyzed according to randomized assignment, or whether imputation or sensitivity analyses were used.

In general, complete-case analyses can be biased when the likelihood of having an observed outcome is related to the outcome itself or to factors associated with it. Methods that use all available observations also rely on assumptions about missingness. The missing-data assumptions and analysis population are not reported in the registry record. The record therefore does not establish whether the follow-up losses altered the estimated results or how robust any result would be to alternative assumptions.

11. Safety Results

The registry reports serious adverse events as affected participants divided by participants at risk.

ArmParticipants with serious adverse eventsParticipants at riskPercentage
Video-based Intervention02290.0%
Assessment Only01210.0%

Deaths

ArmDeaths (participants affected of at risk)
Video-based Intervention0 of 229
Assessment Only0 of 121

Other (non-serious) adverse events

Participants with at least one non-serious event at or above the registry's 0% reporting threshold.

ArmParticipants affected of at risk
Video-based Intervention0 of 229
Assessment Only0 of 121
Do not overextend the safety comparison. Serious-adverse-event counts are safety observations, not efficacy outcomes, and should not be combined with the primary result into a single benefit-risk number.

The adverse-event figures list 229 participants at risk in the video-based intervention group and 121 in the assessment-only group. For both groups, the registry record reports zero serious adverse events, zero other adverse events and zero deaths. No serious adverse-event terms are listed.

These figures should be read as the counts recorded in the registry, not as proof that no adverse experiences occurred. The record does not describe how adverse events were solicited, defined, monitored or attributed, or what observation period was used for safety reporting. It also does not provide detail about events outside the listed categories. A zero count in a registry entry means no events were reported in that category for the recorded group; it cannot rule out unreported events or establish that an intervention is free of risk.

The group-specific at-risk counts are not a substitute for the primary outcome analysis. They describe the denominators used for the reported safety counts, whereas the primary outcome concerns a scale of help-seeking intentions at repeated assessments. The registry record does not explain whether the safety population and primary outcome population were defined in the same way.

12. What the Result Does, and Does Not, Mean

The registry record establishes that a randomized, parallel study evaluated a brief video-based intervention and an assessment-only control, with help-seeking behavior named as the primary outcome. That outcome was measured with the ATSPPH, for which higher scores indicate greater treatment-seeking intentions. The record also gives the intended assessment schedule and describes losses before follow-up.

What the record does not establish is the observed effect. It includes no numerical primary outcome means, no between-group estimate, no confidence interval and no reported test result. Thus it cannot show whether scores differed between groups, whether any difference favored one group, or how precise a comparison would be. No conclusion about the intervention’s efficacy can be drawn from the registry record alone.

The measured construct should also be kept in view. The ATSPPH is described as measuring treatment-seeking intentions, not actual service use. Even a reported change in scale scores would speak directly to the measured attitudes or intentions; it would not, without additional evidence, demonstrate a change in care-seeking behavior.

The study summary describes additional goals involving stigma, fear, geographic risk and mental health symptoms, but the registered information does not report findings for those aims. The record’s description of three intervention arrangements also differs from the two named registered arms. That uncertainty limits interpretation of which specific intervention schedule was compared with assessment only.

Finally, absence of reported results must not be read as a null finding. A null result would require an estimate and uncertainty that are compatible with little or no difference under a defined analysis. No such estimate is reported. The accurate conclusion is that the registry record describes the study’s question and outcome measurement but leaves the primary result and its precision unavailable.

13. Why This Trial Matters Statistically

This trial raises several statistical issues common in behavioral intervention research. The outcome is a continuous scale measured repeatedly, so the analysis needs to define how scores at baseline, post-intervention and follow-up contribute to the primary comparison. A single group mean at one assessment, a change from baseline and a longitudinal contrast answer different questions. Clear specification matters for interpretation and for avoiding selective emphasis among multiple time points.

The record also highlights the distinction between an outcome’s label and what its instrument measures. The primary endpoint is called help-seeking behavior, while the stated instrument assesses attitudes toward seeking professional psychological help and indicates treatment-seeking intentions. Keeping that distinction explicit prevents a scale-based result from being overstated as evidence about actual service use.

Missing follow-up is another important consideration. The record reports losses before day 14 and day 30 but does not describe reasons, group distribution or analytic handling. In a repeated-measures study, missing observations can affect both the amount of information available and the validity of estimates, depending on why data are missing. Transparent reporting of those details is needed to judge the robustness of findings.

There are also inconsistencies in the registered description: the enrollment entry differs from the population figure in the summary, and the summary’s intervention arrangements do not align cleanly with the registered arm descriptions. These issues make it harder to identify the precise population and intervention contrast to which a result would apply.

Most importantly, the registry record does not report the primary outcome result. A well-defined design question cannot be answered from outcome definitions alone. Estimates, uncertainty intervals and a clear analysis population are needed to assess what the observed data show.

14. Limitations

Several record-specific limitations constrain interpretation. The enrollment entry is 350, while the brief summary refers to N=1,200. The registry record does not explain the difference, so the intended recruitment target, registered enrollment and analyzed population cannot be connected from the information recorded. The record also gives no account of changes in enrollment over time.

The intervention description is not consistent across entries. The registered intervention is a brief coping video and the registered comparison is assessment only, while the summary describes two video-based schedules and a no-intervention control. The record does not clarify whether the additional schedule was part of the randomized design, how it maps to the registered arms, or which contrast was primary.

The masking entry says single, but does not identify who was masked. Randomization is recorded, but the method of sequence generation and allocation concealment are not reported. The registry record also does not describe adherence, exposure to the video, or whether participants received the intended intervention schedule.

For the primary outcome, the repeated assessment schedule is stated, but the specific primary comparison and analysis method are not. The record does not report numerical estimates, confidence intervals, or results for the primary outcome, and it lists zero analysis entries. It also does not report the statistical plan, multiplicity approach, or analysis population.

Finally, losses before day 14 and day 30 are reported without reasons, group-specific counts or methods for handling missing observations. The record does not provide the observed score distribution or details needed to assess model assumptions. Together, these omissions prevent evaluation of the size, precision and robustness of any intervention effect from the registry information alone.

15. Related Tutorials

16. Related Statistical Calculators

17. Sources

Continue through the Clinical Biostats statistical pathway

Use this trial's endpoint as a starting point for deeper study of effect measures, confidence intervals, and sample-size planning.

18. Record Summary

The registry record describes a completed, randomized, single-masked, parallel study of a brief video-based intervention for healthcare providers during COVID-19, with assessment only as the registered control. Enrollment is listed as 350, while the brief summary refers to N=1,200; the discrepancy is not explained.

Help-seeking behavior is the primary outcome, measured by the ATSPPH, with higher scores indicating greater treatment-seeking intentions. Assessments are described at baseline and post-intervention on day 1, and at day 14 and day 30. The record reports losses before the two follow-ups but does not describe how missing data were handled.

No numerical primary outcome result or analysis is reported in the registry record. The record’s intervention-arm descriptions differ from the study summary, and the statistical plan, primary comparison, analysis population and multiplicity approach are not reported. Safety entries list zero serious adverse events, zero other adverse events and zero deaths in each registered group.

Clinical Biostats